NRGene, announced that Novogene, a leading global provider of genomic services and solutions, will further enhance its strong genomic analysis capabilities by including NRGene’s DeNovoMAGIC2.0 and PanMAGIC solutions in its service offerings.
“As an industry leader in de novo sequencing and assembly, Novogene is pleased to announce the addition of NRGene’s technologies,” said Dr. Ruiqiang Li, founder and chief executive officer of Novogene. “These solutions complement our existing expertise and SOAPdenovo and NovoHeter software for complex genome assembly and will provide our customers with even more detailed biological understanding from genomic data analysis.”
With NRGene’s DeNovoMAGICTM2.0, Novogene’s customers will receive complete, highly accurate genome assemblies in the form of long, phased sequences. NRGene’s PanMAGICTM compares the complete genome sequences of multiple individuals to capture the broad genomic diversity within a pan-genomic view.
NRGene’s recent breakthroughs on the full genome assemblies of multiple wheat species, maize, soybeans, and many other key crops are already impacting the research of scientists and plant breeders seeking to create more productive and hardier varieties of the plants the world most depends on for its nutritional needs.
“The agreement with Novogene is a significant achievement toward our goal of supporting the Chinese agriculture research community,” says NRGene CEO Gil Ronen. “Since China needs to feed 20% of the world’s population using only 10% of the world’s cultivated land, it’s critical that its scientists have access to the best tools to quickly breed new farm animals and more productive seed varieties. The agreement with Novogene helps accelerate that process, as Novogene already supports the genetic research of thousands of institutions across China and the globe with the world’s largest sequencing capacity and innovative data analysis solutions.”